L
LTP
LTR PHARMA LIMITED
0.385
-0.005-1.28%Closed15:25 05/22 AEST
OPEN/PREV CLOSE0.365/0.355
TODAY RANGE0.365-0.385
VOL236.78K
MARKET CAP68.17M
52 WEEK RANGE0.270-0.810
AVG VOL (3M)378.99K
% TURNOVER0.13%
TURNOVER89.35K
P/E (TTM)-7.5911
% RANGE5.63%
EPS(TTM)-0.0494
P/E(FORWARD)--
P/B2.535
BVPS0.148
DIVIDEND--
P/S32.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP39.51M
SHARES OUTSTANDING181.78M
NEXT EARNINGS--
FREE FLOAT105.35M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·04/30 23:20
Investor Presentation
ASX·04/30 23:20
SPONTAN Phase II data show rapid onset, support FDA pathway
ASX·04/29 00:00
Trading Halt
ASX·04/28 00:00
LTR Pharma Ltd Prelim Q3
ASX·03/10 21:42
Investor Presentation
ASX·03/04 21:33
SPONTAN Phase II Clinical Study Completes Recruitment
ASX·02/25 21:18
Appendix 4D and Half Yearly Report
ASX·02/10 01:22
Application for quotation of securities - LTP
ASX·02/01 21:48
SPONTAN Shows Positive Outcomes in Younger Men with ED
ASX·01/27 21:29
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/21 21:54
First Patients Dosed in SPONTAN Phase II Clinical Study
ASX·01/21 04:36
Application for quotation of securities - LTP
ASX·01/16 05:59
Notification regarding unquoted securities - LTP
ASX·01/12 21:24
Patient Recruitment Commences for SPONTAN Phase II Study
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others